Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis
about
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisGastroenterologyHistologic scoring indices for evaluation of disease activity in ulcerative colitis.European evidence-based Consensus on the management of ulcerative colitis: Current management.Optimum dose of olsalazine for maintaining remission in ulcerative colitis.Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretionDrug therapy of ulcerative colitisOlsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind studyReview article: monitoring for drug side-effects in inflammatory bowel disease.Optimizing management of distal ulcerative colitis.Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.Medical treatment of ulcerative colitis: scoring the advances.Current management of inflammatory bowel disease.Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.New salicylates as maintenance treatment in ulcerative colitis.Clinical pharmacology and therapeutics.Olsalazine-related diarrhoea: does rat intestine adapt in vivo?Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.
P2860
Q24185774-2A26D9A8-EBAE-4CF0-9470-F3552FF584E7Q24198786-37C10AFE-6915-4512-AFD0-946A5D25A7EFQ24246085-1085BDC7-7C58-41F9-96C0-7C19B456781AQ27486369-221AD482-6CBA-4317-8A1A-2E670AA92337Q30234366-7D007CCF-F31F-4ABC-9062-3FDC0D50121EQ34025054-C83A21AE-8B16-4626-8B77-37E7609A07A4Q34382072-AFF25554-12A8-438E-914D-3C3436EE156DQ34393049-71BFBF58-003D-4B45-9A59-A350E023877FQ34403155-AA41D69C-0756-4844-8292-410EB5F7C523Q34532266-7D41CAB5-E3EB-4C52-AB70-8A14FFF967C9Q34585315-3F6CC53A-AC11-4574-AAA0-820892511AA8Q36459902-9EC3D11B-8635-4D59-AE95-0C867766D6A9Q36930800-9372B63A-0259-4BFE-81EE-A5737A77E1B8Q39545180-65E82EFB-E494-4727-B9DF-554F16FEB755Q40708437-3C009F0E-A6D4-44E8-A974-BF7E164DA1D7Q42682893-DC8C1BD2-4C61-49F0-9C98-BF8959BFC0D8Q43215188-9D0FC3A8-4604-46D5-8CDA-825438395A1AQ43263960-3A456D9D-927D-4E43-9BCE-FC08FFD5962AQ44063610-E77226EB-0E43-4176-85F8-23EE71517359Q45295209-5472DA8F-C957-4795-8B67-B7DC10A8F762
P2860
Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Controlled trial comparing ols ...... reatment of ulcerative colitis
@ast
Controlled trial comparing ols ...... reatment of ulcerative colitis
@en
Controlled trial comparing ols ...... reatment of ulcerative colitis
@nl
type
label
Controlled trial comparing ols ...... reatment of ulcerative colitis
@ast
Controlled trial comparing ols ...... reatment of ulcerative colitis
@en
Controlled trial comparing ols ...... reatment of ulcerative colitis
@nl
prefLabel
Controlled trial comparing ols ...... reatment of ulcerative colitis
@ast
Controlled trial comparing ols ...... reatment of ulcerative colitis
@en
Controlled trial comparing ols ...... reatment of ulcerative colitis
@nl
P2093
P2860
P356
P1433
P1476
Controlled trial comparing ols ...... reatment of ulcerative colitis
@en
P2093
P2860
P304
P356
10.1136/GUT.29.6.835
P407
P577
1988-06-01T00:00:00Z